Imipenem | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Imipenem
U.S. EXCLUSIVITIES

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Imipenem

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 13 USDMF, 3 CEP/COS, 2 JDMF, 1 EU WC, 3 KDMF, 3 NDC API, 8 Listed Suppliers, $ API Reference Price

23 API Suppliers
13 USDMF
3 CEP/COS
2 JDMF
1 EU WC
3 KDMF
3 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

48 FDF Dossiers, 13 FDA Orange Book, 10 Europe, 4 Canada, 9 South Africa, 12 Listed Dossiers

48 FDF Dossiers
13 FDA Orange Book
10 Europe
4 Canada
9 South Africa
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL;250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 500MG BASE/VIAL;500MG/VIAL

POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL;250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
POWDER;INTRAVENOUS - EQ 500MG BASE/VIAL;500MG/VIAL

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 SPI Pharma

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 20 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 10 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
10 Finished Drug Prices
10 Annual Reports

MARKET PLACE

14 APIs, 4 FDF Dossiers

14 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 2 US Exclusivities

3 US Patents
2 US Exclusivities

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

1 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 1,465 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 2MSD MERCK CO

filter Product Reset all filters

2 All

01 2CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

filter Exclusivity Expiration Date Reset all filters

2 All

01 12024-07-16

02 12029-07-16

filter Exclusivity Code Reset all filters

2 All

01 1GAIN

02 1NCE

Product Main Page

MSD MERCK CO

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2029-07-16

Application Number

212819

Product Number

1

Exclusivity Details

01

MSD MERCK CO

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Pharma, Lab & Chemical Expo

Not Confirmed

MSD MERCK CO

Singapore

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2029-07-16

Application Number : 212819

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

MSD MERCK CO

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2024-07-16

Application Number

212819

Product Number

1

Exclusivity Details

02

MSD MERCK CO

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Pharma, Lab & Chemical Expo

Not Confirmed

MSD MERCK CO

Singapore

Pharma, Lab & Chemical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Exclusivity Code : NCE

Exclusivity Expiration Date : 2024-07-16

Application Number : 212819

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?